Australia's CSL hits 9-year low after US scraps mandatory flu vaccines for military

Csl

23/04/2026 06:23

** Shares of CSL Ltd CSL.AX fall as much as 1% to A$127.85, its lowest since Aug 31, 2017

** Stock extends previous session's near-6% drop, on track for third straight day of losses

** U.S. defense department said on Tuesday that military personnel would no longer be mandated to receive the flu vaccine

** Biotech firm is heavily exposed to the U.S., its largest revenue source

** Firm's vaccines business, including influenza shots supplied through unit CSL Seqirus, is one of its most profitable divisions

** YTD, stock down 25.4%

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))